Home
>
National Drug Code (NDC)
>
TRIPLE ANTIBIOTIC
TRIPLE ANTIBIOTIC - 0472-0179-56 - (bacitracin zinc neomycin sulfate polymyxin b sulfate)
Drug Information of TRIPLE ANTIBIOTIC
| Product NDC: | 0472-0179 |
| Proprietary Name: | TRIPLE ANTIBIOTIC |
| Non Proprietary Name: | bacitracin zinc neomycin sulfate polymyxin b sulfate |
| Active Ingredient(s): | 400; 3.5; 5000 [iU]/g; mg/g; [iU]/g & nbsp; bacitracin zinc neomycin sulfate polymyxin b sulfate |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | OINTMENT |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of TRIPLE ANTIBIOTIC
| Product NDC: | 0472-0179 |
| Labeler Name: | Actavis Mid Atlantic LLC |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part333B |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20030101 |
Package Information of TRIPLE ANTIBIOTIC
| Package NDC: | 0472-0179-56 |
| Package Description: | 28 g in 1 TUBE (0472-0179-56) |
NDC Information of TRIPLE ANTIBIOTIC
| NDC Code | 0472-0179-56 |
| Proprietary Name | TRIPLE ANTIBIOTIC |
| Package Description | 28 g in 1 TUBE (0472-0179-56) |
| Product NDC | 0472-0179 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | bacitracin zinc neomycin sulfate polymyxin b sulfate |
| Dosage Form Name | OINTMENT |
| Route Name | TOPICAL |
| Start Marketing Date | 20030101 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | Actavis Mid Atlantic LLC |
| Substance Name | BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE |
| Strength Number | 400; 3.5; 5000 |
| Strength Unit | [iU]/g; mg/g; [iU]/g |
| Pharmaceutical Classes |
